✦ LIBER ✦

Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers

✍ Scribed by Yu Wang; Yasushi Adachi; Arisa Imsumran; Hiroyuki Yamamoto; Wenhua Piao; Hua Li; Masanori Ii; Yoshiaki Arimura; Mi Young Park; Dalrae Kim; Choon-Taek Lee; David P. Carbone; Kohzoh Imai; Yasuhisa Shinomura

Book ID: 106180576
Publisher: Springer Japan
Year: 2009
Tongue: English
Weight: 643 KB
Volume: 45
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-009-0151-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

INSULIN-LIKE GROWTH FACTOR-I RECEPTOR AS

INSULIN-LIKE GROWTH FACTOR-I RECEPTOR AS A CANDIDATE FOR A NOVEL MOLECULAR TARGET IN GASTROINTESTINAL CANCERS

✍ Yasushi Adachi; Hiroyuki Yamamoto; Arisa Imsumran; Toshikuni Oka; Mariko Oki; Ka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Blocking the insulin-like growth factor-

Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer

✍ Francesco Hofmann; Carlos García-Echeverría 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A new target for microsatellite instabil

A new target for microsatellite instability in gastrointestinal cancer: Microsatellite instability in the insulin-like growth factor ii receptor gene in gastrointestinal tumours

✍ Stephen A. Bustin 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

The insulin-like growth factor I recepto

The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer

✍ Anna Almeida; Martine Muleris; Bernard Dutrillaux; Bernard Malfoy 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

We report the amplification and overexpression of the IGFlR (insulin-like growth factor I receptor) gene in primary breast cancers with an amplification of band I5q26. The involvement of IGFIR, which may vary in frequency from 2-3% in unseleaed tumor series to more than 10% in breast cancers with hs

Insulin-like growth factor-I receptor bl

Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45

✍ Hua Li; Yasushi Adachi; Hiroyuki Yamamoto; Yongfen Min; Hirokazu Ohashi; Masanor 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

Development of the Monoclonal Antibody F

Development of the Monoclonal Antibody Figitumumab, Targeting the Insulin-like Growth Factor-1 Receptor, for the Treatment of Patients with Non–Small-Cell Lung Cancer

✍ Antonio Gualberto; Daniel D. Karp 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 374 KB